InsidersTradesSigma
Isofol Medical AB (publ): insider trades · Finland · FIN-FSA
FI:isofol-medical-ab-publ-3cbb38SE0025197528FI·FIN-FSAMcap 245M€Healthcare
Discover the full directors' dealings record of Isofol Medical AB (publ), a listed issuer based in Finland. Shares are listed on FI FI, under the supervision of FIN-FSA. Operating in the Healthcare sector, Isofol Medical AB (publ) has published 5 insider filings. Market capitalisation: €244.5m. The latest transaction was filed on 3 July 2025 (Purchase). Among the most active insiders: Margareta Hagman. Every trade is free.
5
Insider Decl.
0
Thresholds
€13,170
4 ops.
Buy Volume
€271
1 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
0.76 €
Analyst consensus
2 analysts1.90 €Target 3.60 €(+372%)5.30 €
Income statement
Net income−54.2 M€0.0% margin
Valuation
PER (forward)-6.6x
P/Book2.0x
Beta0.92
Balance sheet & cash
Market cap244.5 M€
Total debt3.9 M€
Free Cash Flow−51.9 M€
Profitability & ownership
ROE-58.3%
ROA-30.0%
% insiders20.3%
% institutions13.0%
Last declaration on 3 July 2025
Declarations5 total
Executives●Purchase29FIN-FSA
€6,1757,222 shares@ €0.8550.0025% mcap95.0% of flow
BTU (betald tecknad unit)
FI:A003Q438-1·
Ideal exit: 29 Mar 2026 (T+270)
Executives●Purchase32FIN-FSA
€2,0622,412 shares@ €0.8550.0008% mcap88.4% of flow
BTU (betald tecknad unit)
FI:A003Q427-1·
Ideal exit: 29 Mar 2026 (T+270)
Executives●Purchase17FIN-FSA
€4,6095,000 shares@ €0.92180.0019% mcap100.0% of flow
BTU (betald tecknad unit)
FI:A003Q419-1·
Ideal exit: 30 Mar 2026 (T+270)
Executives●Purchase21FIN-FSA
€32490,000 shares@ €0.00360.0001% mcap5.0% of flow
Teckningsrätt/Uniträtt
FI:A003Q300-1·
Ideal exit: 24 Mar 2026 (T+270)
Executives●Sale25FIN-FSA
€27133,408 shares@ €0.00810.0001% mcap11.6% of flow
Teckningsrätt/Uniträtt
FI:A003Q152-1·
5 of 5 declarations